TriArm Therapeutics is a cell therapy company. It offers a DEACT platform ensuring the supply of stem cell-derived immune cells and synergistic actions among immune cells. The company also provides a Sleeping Beauty platform, a non-viral gene transfer technology, and a HiSAFE platform that improves the safety of CAR T cells.